HIV Drug May Slow Down Metastatic Triple-Negative Breast Cancer

Researchers at the Kimmel Cancer Center, led by Dr. Richard G. Pestell have discovered that FDA-approved HIV drugs may stop triple-negative breast cancer from spreading to other organs in pre-clinical models. These results were originally reported in Cancer Research. Recent articles about this discovery have also appeared in NewsWise and the Philadelphia Inquirer.


Drugs targeting chromosomal instability may fight a particular breast cancer subtype

Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson’s Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of Cancer Biology, have shown in a study published online Feb. 6 in the Journal of Clinical Investigation …


The Great Walk

Dr. Richard Pestell joins Olivia Newton-John to recognize donations received from grateful donors as part of The Great Walk to Beijing international fundraising effort.Olivia Newton-John is delighted to accept these funds, raised from over 830 donors, for her Olivia Newton-John Cancer & Wellness Centre in Victoria, Australia.


Get Healthy Philadelphia Tobacco Policy and Control Speaker Series

On March 25th, the Jefferson School of Population Health and Philadelphia Department of Health hosted a seminar featuring Rosemarie Henson, MSSW, MPH. Ms. Henson is the Senior Advisor to the Assistant Secretary for Health at the Department of Health and Human Service (DHHS). Prior to her position at DHHS, Ms. Henson directed multiple disease prevention …


Dr. Pestell and the Thomas Jefferson University Hospital to be honored by the Susan G. Komen for the Cure

Dr. Richard Pestell, Director of the Kimmel Cancer Center at Jefferson, will receive the “Light of Life” award at the 2010 Susan G. Komen Pink Tie Ball on Saturday, October 16.  Also that evening the “Beacon of Hope” award to the Thomas Jefferson University Hospital  will be accepted by Thomas J. Lewis, President and CEO, …


The Ramblewood Country Club Hosted John Runyan’s 2010 “Score For The Cure” Golf Tournament

The Ramblewood  Country Club in Mount Laurel, NJ hosted John Runyan’s 2010 “Score For The Cure” Golf Tournament on September 21st 2010. The proceeds benefited the Kimmel Cancer Center of Jefferson. Dietz & Watson was the Title Sponsor of the event. This  marks the 6th year of the event which has raised nearly $1,000,000 in …


Medical Oncology Adds Drs. Mark Weiss and William Kevin Kelly

Mark Weiss, M.D., has been appointed Director of the Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Division in the Department of Medical Oncology.  He is an internationally respected and renowned expert in the field of hematologic malignancies, particularly CLL and ALL.  Dr. Weiss brings more than 20 years of clinical and investigational experience with him …


Dietz & Watson Present Check From 2009 Runyan “Score For The Cure” Golf Tournament

Dr. Richard Pestell accepts a $10,000 check from Craig Kaplan, MilkBoy Communications, on behalf of Dietz and Watson for Jon Runyan’s “Score for the Cure” Golf Tournament. The tournament last year was a great success. To date, they have raised nearly $1,000,000 in the fight against prostate cancer. The sixth annual Jon Runyan “Score for …


The Quintin Foundation Hosts Martini Tasting Event To Benefit The Kimmel Cancer Center At Jefferson

The Quintin Foundation hosted their 4th Annual Martini Tasting Event on Sunday April 18, 2010 from 2-5 pm at Steve and Cookies, 9700 Amhearst Avenue in Margate. The event featured all of the latest trends in top shelf vodka flavors as well as a variety of beers which will be paired with an assortment of …


Jefferson Commencement Honorees

Drs. Edward C. Bradley, Benjamin S. Carson and Raymond C. Grandon were awarded a Doctor of Science honorary degree from Thomas Jefferson University at the Jefferson Medical College, Jefferson College of Graduate Studies and Jefferson School of Population Health Commencement ceremony on May 24, 2010 at the Kimmel Center for the Performing Arts. Dr. Carson …


Small RNA Molecules Block Breast Cancer from Spreading via Newly Identified Secreted Factor

The role of genes and proteins in cancer control is well known, but now researchers at Jefferson’s Kimmel Cancer Center have found a cluster of microRNA (miRNA) molecules that act to suppress the invasive spread of breast cancer. MiRNAs are non-coding small RNA molecules found in wide areas of the genome that, either singly or …


Kimmel Cancer Center Director Awarded R. Douglas Wright Medallion at the University of Melbourne, Australia

Richard G. Pestell, M.D., Ph.D., FACP, FRACP, Director of the Kimmel Cancer Center at Jefferson, was honored with the R. Douglas Wright Medallion and delivered the R. Douglas Wright Lecture at the University of Melbourne in Australia. The award is given in the areas of science, literature, economics and politics. Prior recipients include Sir James …


KCC American Cancer Society Research Symposium

The Kimmel Cancer Center at Jefferson hosted the 2nd Annual American Cancer Society Research Symposium: Celebrating the ACS Institutional Research Grant at KCC on April 16, 2010. Dr. Pestell welcomed members of the KCC and TJU community and the American Cancer Society. Michael Lisanti, MD, PhD was the Keynote Speaker presenting “The Reverse Warburg Effect: …


Second Annual Get Your Rear In Gear Event

The second annual Philadelphia Get Your Rear In Gear will took  place at 7:30 a.m. on Martin Luther King Drive in Philadelphia, Sunday, March 21, 2010, during National Colorectal Cancer Awareness Month.  Both survivors and those lost to colorectal cancer were honored.  There was a 5K Race  and a 2 mile Remembrance Walk. Results are …


New Universal Breast Cancer Marker Predicts Recurrence

The marker appears to be widely applicable to all breast cancer patients, regardless of other established prognostic indicators Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, …